Relationship Between EBV and PTLD
Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease
Sponsor: Children's Healthcare of Atlanta
Terminated
sufficient data gathered to support conclusion
Other terminated trials from Children's Healthcare of Atlanta
Listed as NCT00215033, this observational or N/A phase trial focuses on Pediatric Heart Transplant and remains terminated or withdrawn. Sponsored by Children's Healthcare of Atlanta, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Healthcare of Atlanta
For direct contact, visit the study record on ClinicalTrials.gov .